By targeting activated immune cells in both the periphery and affected tissues, we modulate the critical pathways that regulate autoimmunity and inflammation.

Dysregulated immune responses fuel a wide range of autoimmune and inflammatory diseases across gastroenterology, rheumatology, dermatology and respiratory therapeutic areas. These large, underserved patient populations often receive treatments that fall short, and our science aims to make a meaningful difference.